Cardioprotective effects of troglitazone in streptozotocin-induced diabetic rats
Authors:
- Michio ShimabukuroMSMichio Shimabukuro
- Satoshi HigaSHSatoshi Higa
- Tatsushi ShinzatoTSTatsushi Shinzato
- Fumio NagamineFNFumio Nagamine
- Ichiro KomiyaIKIchiro Komiya
- Nobuyuki TakasuNTNobuyuki Takasu
- 1 September 1996
- journal article
- Published by Elsevier in Metabolism
- Vol. 45 (9) , 1168-1173
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Long-term nifedipine treatment reduces calcium overload in isolated reperfused hearts of diabetic ratsGeneral Pharmacology: The Vascular System, 1995
- Impaired Mechanical Response to Calcium of Diabetic Rat HeartsJournal of Cardiovascular Pharmacology, 1995
- Chronic gliclazide treatment affects basal and post-ischemic cardiac function in diabetic ratsGeneral Pharmacology: The Vascular System, 1994
- The diabetic heart: metabolic causes for the development of a cardiomyopathyCardiovascular Research, 1992
- Effects of Probucol on Impaired Cardiac Performance and Lipid Metabolism in Streptozotocin-Induced Diabetic RatsJournal of Cardiovascular Pharmacology, 1992
- The effect of sulfonylurea therapy on defective calcium movement associated with diabetic cardiomyopathyCanadian Journal of Physiology and Pharmacology, 1989
- Structural manifestations of diabetic cardiomyopathy in the rat and its reversal by insulin treatmentJournal of Anatomy, 1988
- Reversibility of diabetic cardiomyopathy with insulin in rats.Circulation Research, 1981
- The effect of diabetes on performance and metabolism of rat hearts.Circulation Research, 1980
- Diabetes Mellitus Induces Changes in Cardiac Myosin of the RatDiabetes, 1980